Compare ILMN & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ILMN | ALC |
|---|---|---|
| Founded | 1998 | 1945 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.3B | 34.1B |
| IPO Year | 2000 | 2002 |
| Metric | ILMN | ALC |
|---|---|---|
| Price | $211.37 | $69.39 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 17 | 12 |
| Target Price | ★ $124.24 | $89.38 |
| AVG Volume (30 Days) | ★ 1.6M | 1.4M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.25% |
| EPS Growth | ★ 170.87 | N/A |
| EPS | ★ 2.22 | N/A |
| Revenue | ★ $4,343,000,000.00 | N/A |
| Revenue This Year | $6.47 | $7.99 |
| Revenue Next Year | $5.58 | $6.38 |
| P/E Ratio | $95.07 | ★ $38.31 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $88.00 | $61.84 |
| 52 Week High | $231.81 | $87.64 |
| Indicator | ILMN | ALC |
|---|---|---|
| Relative Strength Index (RSI) | 54.52 | 38.66 |
| Support Level | $182.76 | $66.08 |
| Resistance Level | $231.81 | $69.75 |
| Average True Range (ATR) | 9.45 | 1.09 |
| MACD | -0.77 | -0.53 |
| Stochastic Oscillator | 51.24 | 7.62 |
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.